More about

Autoimmune And Rheumatic Diseases

News
October 22, 2024
3 min read
Save

Patients report rheumatic disease improvement after swapping certain drugs for cannabis

Nearly two-thirds of patients with rheumatic diseases reported swapping NSAIDs, opioids, sleep aids or muscle relaxants with medical cannabis, with most reporting higher symptom improvement with the cannabis, according to data.

News
October 21, 2024
2 min read
Save

Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine

Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.

News
October 18, 2024
6 min read
Save

‘Devouring’ the market? Walmart to quintuple its autoimmune specialty pharmacy locations

The largest retailer in the nation has sampled a taste of the autoimmune specialty pharmacy market, and has decided it wants more.

News
October 16, 2024
2 min read
Save

Biosimilar retention not impacted by comorbidities in inflammatory RMDs

The presence of comorbidities with inflammatory rheumatic musculoskeletal diseases made little difference in biosimilar retention after a non-medical switch, according to data published in Arthritis Research & Therapy.

News
October 16, 2024
3 min read
Save

Raynaud’s disease most severe at very low temperatures, also ‘troublesome’ above 35°C

The severity of Raynaud’s disease is greatest at very low temperatures, but can also increase in hot environments that reach 35°C and above, according to data published in The Lancet Rheumatology.

News
October 10, 2024
2 min read
Save

Systemic treatment reduces risk for new Sjögren’s disease activity in presence of lymphoma

Systemic treatment strategies lower the risk for new Sjögren’s disease activity when there are complications with marginal zone lymphoma, according to a study published in The Lancet Rheumatology.

News
October 01, 2024
2 min read
Save

Dual therapy can have ‘synergistic effect’ in difficult-to-treat inflammatory diseases

SAN DIEGO — Certain dual therapy strategies, including interleukin-17 plus IL-23 inhibition, or Janus kinase inhibitors alongside TNF inhibitors, can be effective for difficult-to-treat inflammatory diseases, according to a speaker here.

News
September 29, 2024
2 min read
Save

‘Very little evidence’ that COVID-19 alters course of rheumatic, autoimmune diseases

SAN DIEGO — Although a flood of COVID-19 and long COVID research continues to emerge, concerns may be limited for rheumatologists, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

News
September 26, 2024
1 min read
Save

Severe disease, strict endpoints in CAR T trials 'could be a way through the regulators'

SAN DIEGO — Regulatory trials of chimeric antigen receptor T-cell therapies for autoimmune diseases could be successful with a focus on patients with severe disease and strict endpoints, according to a speaker.

News
September 24, 2024
2 min read
Save

Among herbal supplements, elderberry poses greatest risks in autoimmune skin disease

Use of elderberry as an herbal supplement preceded disease exacerbation in 62% of patients with dermatomyositis, and in 50% of those with cutaneous lupus erythematosus, according to data published in ACR Open Rheumatology.

View more